• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 中的 NOX2 激活:对神经退行性疾病的可能影响。

NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.

机构信息

IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.

出版信息

Medicina (Kaunas). 2021 Jun 11;57(6):604. doi: 10.3390/medicina57060604.

DOI:10.3390/medicina57060604
PMID:34208136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8230853/
Abstract

Coronavirus disease 2019 (COVID-19) is a rapidly spreading contagious infectious disease caused by the pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that primarily affects the respiratory tract as well as the central nervous system (CNS). SARS-CoV-2 infection occurs through the interaction of the viral protein Spike with the angiotensin II receptor (ACE 2), leading to an increase of angiotensin II and activation of nicotinamide adenine dinucleotide phosphate oxidase2 (NOX2), resulting in the release of both reactive oxygen species (ROS) and inflammatory molecules. The purpose of the review is to explain that SARS-CoV-2 infection can determine neuroinflammation that induces NOX2 activation in microglia. To better understand the role of NOX2 in inflammation, an overview of its involvement in neurodegenerative diseases (NDs) such as Parkinson's disease (PD), Alzheimer's disease (AD), and amyotrophic lateral sclerosis (ALS) is provided. To write this manuscript, we performed a PubMed search to evaluate the possible relationship of SARS-CoV-2 infection in NOX2 activation in microglia, as well as the role of NOX2 in NDs. Several studies highlighted that NOX2 activation in microglia amplifies neuroinflammation. To date, there is no clinical treatment capable of counteracting its activation, however, NOX2 could be a promising pharmaceutical target useful for both the treatment and prevention of NDs and COVID-19 treatment.

摘要

新型冠状病毒病 2019(COVID-19)是一种由病原体严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的快速传播的传染病,主要影响呼吸道和中枢神经系统(CNS)。SARS-CoV-2 感染通过病毒蛋白 Spike 与血管紧张素 II 受体(ACE2)的相互作用发生,导致血管紧张素 II 增加和烟酰胺腺嘌呤二核苷酸磷酸氧化酶 2(NOX2)的激活,从而导致活性氧(ROS)和炎症分子的释放。本综述的目的是解释 SARS-CoV-2 感染可以确定神经炎症,诱导小胶质细胞中 NOX2 的激活。为了更好地理解 NOX2 在炎症中的作用,概述了其在神经退行性疾病(NDs)中的作用,如帕金森病(PD)、阿尔茨海默病(AD)和肌萎缩侧索硬化症(ALS)。为了撰写本文,我们进行了 PubMed 搜索,以评估 SARS-CoV-2 感染与小胶质细胞中 NOX2 激活之间的可能关系,以及 NOX2 在 NDs 中的作用。多项研究强调,小胶质细胞中 NOX2 的激活会放大神经炎症。迄今为止,尚无能够对抗其激活的临床治疗方法,但是,NOX2 可能是一种有前途的药物靶点,对 NDs 和 COVID-19 的治疗和预防都有帮助。

相似文献

1
NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.COVID-19 中的 NOX2 激活:对神经退行性疾病的可能影响。
Medicina (Kaunas). 2021 Jun 11;57(6):604. doi: 10.3390/medicina57060604.
2
COVID-19 and neurodegenerative diseases.COVID-19 与神经退行性疾病。
Eur Rev Med Pharmacol Sci. 2022 Jun;26(12):4535-4544. doi: 10.26355/eurrev_202206_29093.
3
Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases.阐明 COVID-19 在神经退行性疾病发展中潜在作用的分子机制。
Physiol Int. 2022 Jun 6;109(2):135-162. doi: 10.1556/2060.2022.00019. Print 2022 Jun 16.
4
Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.雌激素在 COVID-19 中的治疗应用:抑制 SARS-CoV-2 刺突蛋白和 IL-6 刺激、ACE2 依赖性 NOX2 激活、ROS 产生和内皮细胞中 MCP-1 的上调。
Redox Biol. 2021 Oct;46:102099. doi: 10.1016/j.redox.2021.102099. Epub 2021 Aug 17.
5
Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.探索 COVID-19 在神经并发症中的悖论,重点关注帕金森病和阿尔茨海默病。
Oxid Med Cell Longev. 2022 Aug 31;2022:3012778. doi: 10.1155/2022/3012778. eCollection 2022.
6
Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?严重急性呼吸综合征冠状病毒 2 对中枢神经系统的影响:星形胶质细胞和小胶质细胞是主要参与者还是仅仅是旁观者?
ASN Neuro. 2020 Jan-Dec;12:1759091420954960. doi: 10.1177/1759091420954960.
7
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.Eph 受体、神经纤毛蛋白-1、P2X7 和 CD147 在 COVID-19 相关神经退行性疾病中的作用:炎症小体和 Jak 抑制剂作为有前途的潜在治疗方法。
Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1.
8
Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.SARS-CoV-2 是否会影响神经退行性疾病?TLR2,中枢神经系统中 SARS-CoV-2 的潜在受体。
Exp Mol Med. 2022 Apr;54(4):447-454. doi: 10.1038/s12276-022-00755-7. Epub 2022 Apr 8.
9
Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.基质金属蛋白酶在神经退行性疾病中的多效性作用:病理生理和治疗观点。
Int J Mol Sci. 2021 Jan 30;22(3):1413. doi: 10.3390/ijms22031413.
10
Dialogue between Neuroinflammation and Neurodegenerative Diseases in COVID-19.新冠病毒感染中的神经炎症与神经退行性疾病的对话。
J Environ Pathol Toxicol Oncol. 2021;40(3):37-49. doi: 10.1615/JEnvironPatholToxicolOncol.2021038365.

引用本文的文献

1
Identification of Putative Serum Autoantibodies Associated with Post-Acute Sequelae of COVID-19 via Comprehensive Protein Array Analysis.通过综合蛋白质阵列分析鉴定与 COVID-19 急性后遗症相关的推定血清自身抗体
Int J Mol Sci. 2025 Feb 19;26(4):1751. doi: 10.3390/ijms26041751.
2
Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer's Disease.减少新冠病毒在大脑中的淀粉样蛋白沉积并预防新冠病毒加剧的痴呆症和阿尔茨海默病的潜在策略。
Pharmaceuticals (Basel). 2024 Jun 16;17(6):788. doi: 10.3390/ph17060788.
3
Inhibition of NADPH oxidase 2 enhances resistance to viral neuroinflammation by facilitating M1-polarization of macrophages at the extraneural tissues.抑制 NADPH 氧化酶 2 可通过促进神经外组织中巨噬细胞的 M1 极化来增强对病毒神经炎症的抵抗力。
J Neuroinflammation. 2024 May 2;21(1):115. doi: 10.1186/s12974-024-03078-8.
4
Inositol Hexaphosphate as an Inhibitor and Potential Regulator of p47 Membrane Anchoring.六磷酸肌醇作为 p47 膜锚定的抑制剂和潜在调节剂。
Biochemistry. 2024 May 7;63(9):1097-1106. doi: 10.1021/acs.biochem.4c00117. Epub 2024 Apr 26.
5
Does COVID-19 Trigger the Risk for the Development of Parkinson's Disease? Therapeutic Potential of Vitamin C.COVID-19 是否会引发帕金森病的风险?维生素 C 的治疗潜力。
Mol Neurobiol. 2024 Dec;61(12):9945-9960. doi: 10.1007/s12035-023-03756-3. Epub 2023 Nov 14.
6
The Impact of Serum Levels of Reactive Oxygen and Nitrogen Species on the Disease Severity of COVID-19.活性氧和氮物种血清水平对 COVID-19 疾病严重程度的影响。
Int J Mol Sci. 2023 May 18;24(10):8973. doi: 10.3390/ijms24108973.
7
Aerobic Physical Training Attenuates Oxidative Stress in the Spinal Cord of Adult Rats Induced by Binge-like Ethanol Intake.有氧体育训练减轻成年大鼠因暴饮样乙醇摄入诱导的脊髓氧化应激。
Antioxidants (Basel). 2023 May 5;12(5):1051. doi: 10.3390/antiox12051051.
8
Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions.衰老大脑与对新冠病毒的神经免疫反应:急性后遗症以及行为和营养干预的调节作用
Immun Ageing. 2023 Apr 12;20(1):17. doi: 10.1186/s12979-023-00341-z.
9
Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress.癌症和新冠疫情中与氧化应激相关的髓源性抑制细胞
Vaccines (Basel). 2023 Jan 19;11(2):218. doi: 10.3390/vaccines11020218.
10
Advances in the study of nicotinamide adenine dinucleotide phosphate oxidase in myocardial remodeling.心肌重塑中烟酰胺腺嘌呤二核苷酸磷酸氧化酶的研究进展
Front Cardiovasc Med. 2022 Nov 3;9:1000578. doi: 10.3389/fcvm.2022.1000578. eCollection 2022.

本文引用的文献

1
SARS-CoV-2 Spike Targets USP33-IRF9 Axis Exosomal miR-148a to Activate Human Microglia.严重急性呼吸综合征冠状病毒2刺突蛋白靶向USP33-IRF9轴的外泌体miR-148a以激活人小胶质细胞。
Front Immunol. 2021 Apr 14;12:656700. doi: 10.3389/fimmu.2021.656700. eCollection 2021.
2
Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19.新型冠状病毒肺炎亚急性期认知障碍与脑葡萄糖代谢改变。
Brain. 2021 May 7;144(4):1263-1276. doi: 10.1093/brain/awab009.
3
Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic.小胶质细胞为神经和心理健康而战:在新冠疫情的中枢神经系统前线
Front Cell Neurosci. 2021 Feb 18;15:647378. doi: 10.3389/fncel.2021.647378. eCollection 2021.
4
Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19.新型冠状病毒感染炎症的神经表现及 COVID-19 的可能治疗策略。
Mol Neurobiol. 2021 Jul;58(7):3417-3434. doi: 10.1007/s12035-021-02318-9. Epub 2021 Mar 14.
5
Implication of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Its Inhibitors in Alzheimer's Disease Murine Models.烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶及其抑制剂在阿尔茨海默病小鼠模型中的作用
Antioxidants (Basel). 2021 Feb 2;10(2):218. doi: 10.3390/antiox10020218.
6
Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?四环素类药物在 COVID-19 神经系统和神经精神表现中的再利用:控制 SARS-CoV-2 相关神经炎症的有效选择?
J Neuroimmune Pharmacol. 2021 Jun;16(2):213-218. doi: 10.1007/s11481-021-09986-3. Epub 2021 Feb 3.
7
Diphenyl diselenide protects motor neurons through inhibition of microglia-mediated inflammatory injury in amyotrophic lateral sclerosis.二苯二硒醚通过抑制小胶质细胞介导的炎症损伤来保护运动神经元在肌萎缩侧索硬化症中的作用。
Pharmacol Res. 2021 Mar;165:105457. doi: 10.1016/j.phrs.2021.105457. Epub 2021 Jan 27.
8
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.德国 COVID-19 患者的神经病理学:一项尸检病例系列研究。
Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.
9
SARS-CoV-2, an Underestimated Pathogen of the Nervous System.严重急性呼吸综合征冠状病毒2(SARS-CoV-2),一种被低估的神经系统病原体。
SN Compr Clin Med. 2020;2(11):2137-2146. doi: 10.1007/s42399-020-00522-7. Epub 2020 Sep 28.
10
Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19.神经纤毛蛋白 1 作为新型潜在的 SARS-CoV-2 感染介质,与 COVID-19 的神经特征和中枢神经系统受累相关。
Mol Med Rep. 2020 Nov;22(5):4221-4226. doi: 10.3892/mmr.2020.11510. Epub 2020 Sep 15.